Key facts
| Recalling firm | KENT IMAGING, INC. |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | SnapshotGLO Wound Imaging Device, Model KB100, KB100AA. |
| Classification | Class II |
| Recall number | Z-2775-2026 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | The software controlling the wound imaging device's battery charging circuit was not designed to recognize and recover a battery that has fully discharged into a low-power "shipping mode." When this occurs, an affected device will not resume charging when reconnected to power and becomes temporarily unusable/ unavailable for wound imaging until corrected. |
What this classification means
A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of SnapshotGLO Wound Imaging Device, Model KB100, KB100AA. should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from KENT IMAGING, INC.. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from KENT IMAGING, INC. should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to KENT IMAGING, INC. directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
KENT IMAGING, INC.’s FDA history
Argus HQ has recorded 1 total FDA action tied to KENT IMAGING, INC.: 0 warning letters, 1 recall, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- What is the FDA recall number for this event?
- FDA recall number Z-2775-2026.
- What is the current status of this recall?
- Status as recorded by FDA: Ongoing.
- Where can I verify this recall directly with FDA?
- The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.
- Is SnapshotGLO Wound Imaging Device, Model KB100, KB100AA. recalled?
- Yes. FDA lists a Class II recall by KENT IMAGING, INC. for SnapshotGLO Wound Imaging Device, Model KB100, KB100AA., reported 20260729, with status "Ongoing." FDA recall number: Z-2775-2026.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for KENT IMAGING, INC.Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Class II Recall: SnapshotGLO Wound Imaging Device, Model KB100, KB100AA. by KENT IMAGING, INC.. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/recall/kent-imaging-z-2775-2026-2026-07-29
"FDA Class II Recall: SnapshotGLO Wound Imaging Device, Model KB100, KB100AA. by KENT IMAGING, INC.." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/recall/kent-imaging-z-2775-2026-2026-07-29.
Argus HQ Research. "FDA Class II Recall: SnapshotGLO Wound Imaging Device, Model KB100, KB100AA. by KENT IMAGING, INC.." Digital Empire Holdings LLC. Accessed August 4, 2026. https://argushq.ai/recall/kent-imaging-z-2775-2026-2026-07-29.
@misc{argushq_argushq_ai_recall_kent_imaging_z_2775_2026_2026_07_29_2026,
title = {FDA Class II Recall: SnapshotGLO Wound Imaging Device, Model KB100, KB100AA. by KENT IMAGING, INC.},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/recall/kent-imaging-z-2775-2026-2026-07-29},
note = {Accessed: August 4, 2026}
}Source: FDA.gov — Recalls ↗